欢迎来到范德生物BIOFOUNT
范德生物中国

中文范德生物中文语言

范德生物产品购买购物车
0
搜索
Voreloxin Hydrochloride_175519-16-1_产品详情
175519-16-1
  • Voreloxin Hydrochloride

  • names:

    Voreloxin Hydrochloride

  • CAS号:

    175519-16-1

    MDL Number:
  • MF(分子式): C18H20ClN5O4S MW(分子量): 437.9
  • EINECS: Reaxys Number:
  • Pubchem ID: Brand:BIOFOUNT
Voreloxin Hydrochloride
货品编码 规格 纯度 价格 (¥) 现价(¥) 特价(¥) 库存描述 数量 总计 (¥)
YZM001372-10mg 10mg 99.7% ¥ 3240.00 ¥ 3240.00 2-3天
- +
¥ 0.00
YZM001372-5mg 5mg 99.7% ¥ 1820.00 ¥ 1820.00 2-3天
- +
¥ 0.00
快速询价
收起
你想询价的产品
请准确填写您的联系方式,以便为您提供最好的服务。
中文别名
英文别名 Voreloxin Hydrochloride
CAS号 175519-16-1
Inchi
InchiKey
分子式 Formula C18H20ClN5O4S
分子量 Molecular Weight 437.9
溶解度Solubility 生物体外In Vitro:DMSO溶解度2 mg/mL(4.57 mM;ultrasonic and warming and heat to 60°C)
性状
储藏条件 Storage conditions 粉末Powder: -20°C 3 years年 4°C 2 years年 / In solvent溶液中:-80°C 6 months月 -20°C 1 month月
产品说明
IntroductionVoreloxin Hydrochloride is a firstnlasstopoisomerase IIinhibitor that intercalates DNA and induces siteelective DNA DSB, G2 arrest, and apoptosis.
Application1
Application2
Application3
Voreloxin Hydrochloride 是一种有效的新创的拓扑异构酶 II (topoisomerase II) 抑制剂,能够诱导 DNA 双链断裂,阻滞 G2 期,最终细胞凋亡。Voreloxin Hydrochloride is a first-in-classtopoisomerase IIinhibitor that intercalates DNA and induces site-selective DNA DSB, G2 arrest, and apoptosis.
警示图
危险性
危险性警示
安全声明
安全防护
备注
【1】.Hotinski AK, et al. Vosaroxin is a novel topoisomerase-II inhibitor with efficacy in relapsed and refractory acute myeloid leukaemia. Expert Opin Pharmacother. 2015 Jun;16(9):1395-402.
【2】.Scatena CD, et al. Voreloxin, a first-in-class anticancer quinolone derivative, acts synergistically with cytarabine in vitro and induces bone marrow aplasia in vivo. Cancer Chemother Pharmacol. 2010 Oct;66(5):881-8.
【3】.Walsby EJ, et al. The topoisomerase II inhibitor voreloxin causes cell cycle arrest and apoptosis in myeloid leukemia cells and acts in synergy with cytarabine. Haematologica. 2011 Mar;96(3):393-9.
    对不起,暂无产品评价!
MSDS
SDS 1.0 中文
展开
SDS 1.0 英文
展开
        新闻
        抱歉,暂无数据!
        My title page contents